Please login to the form below

Not currently logged in

Novartis parts with Eisai to go it alone with COPD drugs

Ends co-promotion agreement for Onbrez, Seebri and QVA149

Novartis building 

Novartis and Eisai have terminated their deal to co-promote three treatments for chronic obstructive pulmonary disease (COPD) in Japan.

The companies have called time on their partnership, which covered Novartis' Onbrez, Seebri and QVA149, just over a year after it was signed.

The November 2011 co-promotion agreement saw Novartis and Eisai conduct a range of “information provision” activities for the drugs.

These saw Novartis' Japanese business concentrate on university and 'flagship' hospitals, while Eisai was tasked with targeting other healthcare providers such as general hospitals and primary care doctors.

At the time Novartis saw the deal as a way to maximise the value of its COPD drugs, while for Eisai it was meant to enhance its internal medicine portfolio.

Eisai said the decision to terminate the agreement, which came after a round of negotiations between the partners, was the result of a “review of sales strategies for the products”.

Novartis will now go it alone in promoting Onbrez Inhalation Capsules 150 mcg (indacaterol maleate) and Seebri Inhalation Capsules 50 mcg (glycopyrronium bromide).

The Swiss pharma company also takes back responsibility for the “provision, gathering and transmission of pharmaceutical information” on QVA149, a combination of Onbrez and Seebri that was filed for Japanese approval in November.

9th January 2013

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...